Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its $21 billion life sciences business. The medical device maker has started ...

Two years ago, when Merck KGaA restructured, forming a new life science business, the goal was to maximize the enticing potential of its contract development and manufacturing organization (CDMO). But ...

During Google's (NASDAQ:GOOG)(NASDAQ:GOOGL) federal trial versus the U.S. Department of Justice in Alexandria, Va., on Thursday, Google's vice president of security engineering, Heather Adkins, said ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.

April 1 (Reuters) - U.S. medical device maker Becton Dickinson (BDX.N), opens new tab is in talks with Thermo Fisher (TMO.N), opens new tab and Danaher (DHR.N), opens new tab for a potential sale of ...